Anti-Spike Mucosal IgA Protection against SARS-CoV-2

New Post Public Reply Private Reply Replies (0) Message Board Keep
redspeed redspeed #1240
311
Post of 1,418
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection - September 14, 2022

Mucosal IgA can provide immunity against respiratory viruses.1 Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) boosts mucosal IgA responses,2 and neutralizing IgA, including neutralizing IgA against the B.1.1.529 (omicron) variant of SARS-CoV-2, has been detected after infection with wild-type SARS-CoV-2.3 However, the potential role of mucosal IgA in protection against SARS-CoV-2 infection is still largely unknown.

https://www.nejm.org/doi/full/10.1056/NEJMc2209651


3cl protease cleaves IgA. Cleave means it split or sever the IgA.

Guess what stops the 3cl protease from replication thus cleaving IgA which provides immunity against respiratory viruses?

If you said Tollovid. BINGO!


Gerald Commissiong@G_Commish
"3CLpro cleaves IgA. We have IP on this. One of the reasons Tollovid is a big deal"

Todos Med Ltd. (TOMDF) Stock Research Links

TOMDF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼